Frailty in Children with Liver Disease: A Prospective Multicenter Study

Eberhard Lurz, Claudia Quammie, Michael Englesbe, Estella M. Alonso, Henry Lin, Evelyn K. Hsu, Katryn N. Furuya, Nitika A. Gupta, Veena L. Venkat, James F. Daniel, Mike A. Leonis, Tamir Miloh, Grzegorz W. Telega, Jason Yap, Jerome Menendez, Linda S. Book, Ryan W. Himes, Shikha S. Sundaram, Rulan Parekh, Chris SonnendayJohn Bucuvalas, Vicky L. Ng, Binita M. Kamath

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To assess frailty, a measure of physiologic declines in multiple organ systems, in children with chronic liver disease using a novel pediatric frailty tool. Study design: We performed a prospective cross-sectional multicenter study at 17 liver transplantation (LT) centers. 71 children (5–17 years of age), 36 with compensated chronic liver disease (CCLD) and 35 with end-stage liver disease (ESLD) and listed for LT, were assessed for frailty using validated pediatric tools to assess the 5 classic Fried Frailty Criteria—slowness, weakness, exhaustion, diminished physical activity, and shrinkage. Test scores were translated to age- and sex-dependent z scores, generating a maximum frailty score of 10. Results: The median frailty score of the cohort was 4 (IQR 3, 5). Subjects with ESLD had significantly higher frailty scores (median 5; IQR 4, 7) than subjects with CCLD (median 3; IQR 2, 4); (P <.0001). Area under the curve receiver operating characteristic for frailty scores to discriminate between ESLD and CCLD was 0.83 (95% CI 0.73, 0.93). Forty-six percent of children with ESLD were frail and there was no correlation between pediatric frailty scores and physician's global assessments (r = -0.24, 95% CI -0.53, 0.10). Conclusions: A novel frailty tool assessed additional dimensions of health, not captured by standard laboratory measures and identified the sickest individuals among a cohort of children with chronic liver disease. This tool may have applicability to other children with chronic disease.

Original languageEnglish (US)
Pages (from-to)109-115.e4
JournalJournal of Pediatrics
Volume194
DOIs
StatePublished - Mar 1 2018
Externally publishedYes

Fingerprint

Multicenter Studies
Liver Diseases
End Stage Liver Disease
Chronic Disease
Prospective Studies
Pediatrics
Liver Transplantation
ROC Curve
Area Under Curve
Cross-Sectional Studies
Exercise
Physicians
Health

Keywords

  • comprehensive clinical assessment
  • end-stage liver disease
  • frailty
  • pediatric liver transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Lurz, E., Quammie, C., Englesbe, M., Alonso, E. M., Lin, H., Hsu, E. K., ... Kamath, B. M. (2018). Frailty in Children with Liver Disease: A Prospective Multicenter Study. Journal of Pediatrics, 194, 109-115.e4. https://doi.org/10.1016/j.jpeds.2017.10.066

Frailty in Children with Liver Disease : A Prospective Multicenter Study. / Lurz, Eberhard; Quammie, Claudia; Englesbe, Michael; Alonso, Estella M.; Lin, Henry; Hsu, Evelyn K.; Furuya, Katryn N.; Gupta, Nitika A.; Venkat, Veena L.; Daniel, James F.; Leonis, Mike A.; Miloh, Tamir; Telega, Grzegorz W.; Yap, Jason; Menendez, Jerome; Book, Linda S.; Himes, Ryan W.; Sundaram, Shikha S.; Parekh, Rulan; Sonnenday, Chris; Bucuvalas, John; Ng, Vicky L.; Kamath, Binita M.

In: Journal of Pediatrics, Vol. 194, 01.03.2018, p. 109-115.e4.

Research output: Contribution to journalArticle

Lurz, E, Quammie, C, Englesbe, M, Alonso, EM, Lin, H, Hsu, EK, Furuya, KN, Gupta, NA, Venkat, VL, Daniel, JF, Leonis, MA, Miloh, T, Telega, GW, Yap, J, Menendez, J, Book, LS, Himes, RW, Sundaram, SS, Parekh, R, Sonnenday, C, Bucuvalas, J, Ng, VL & Kamath, BM 2018, 'Frailty in Children with Liver Disease: A Prospective Multicenter Study', Journal of Pediatrics, vol. 194, pp. 109-115.e4. https://doi.org/10.1016/j.jpeds.2017.10.066
Lurz, Eberhard ; Quammie, Claudia ; Englesbe, Michael ; Alonso, Estella M. ; Lin, Henry ; Hsu, Evelyn K. ; Furuya, Katryn N. ; Gupta, Nitika A. ; Venkat, Veena L. ; Daniel, James F. ; Leonis, Mike A. ; Miloh, Tamir ; Telega, Grzegorz W. ; Yap, Jason ; Menendez, Jerome ; Book, Linda S. ; Himes, Ryan W. ; Sundaram, Shikha S. ; Parekh, Rulan ; Sonnenday, Chris ; Bucuvalas, John ; Ng, Vicky L. ; Kamath, Binita M. / Frailty in Children with Liver Disease : A Prospective Multicenter Study. In: Journal of Pediatrics. 2018 ; Vol. 194. pp. 109-115.e4.
@article{c495aa9e426b48f9ba358798b96c9dd3,
title = "Frailty in Children with Liver Disease: A Prospective Multicenter Study",
abstract = "Objective: To assess frailty, a measure of physiologic declines in multiple organ systems, in children with chronic liver disease using a novel pediatric frailty tool. Study design: We performed a prospective cross-sectional multicenter study at 17 liver transplantation (LT) centers. 71 children (5–17 years of age), 36 with compensated chronic liver disease (CCLD) and 35 with end-stage liver disease (ESLD) and listed for LT, were assessed for frailty using validated pediatric tools to assess the 5 classic Fried Frailty Criteria—slowness, weakness, exhaustion, diminished physical activity, and shrinkage. Test scores were translated to age- and sex-dependent z scores, generating a maximum frailty score of 10. Results: The median frailty score of the cohort was 4 (IQR 3, 5). Subjects with ESLD had significantly higher frailty scores (median 5; IQR 4, 7) than subjects with CCLD (median 3; IQR 2, 4); (P <.0001). Area under the curve receiver operating characteristic for frailty scores to discriminate between ESLD and CCLD was 0.83 (95{\%} CI 0.73, 0.93). Forty-six percent of children with ESLD were frail and there was no correlation between pediatric frailty scores and physician's global assessments (r = -0.24, 95{\%} CI -0.53, 0.10). Conclusions: A novel frailty tool assessed additional dimensions of health, not captured by standard laboratory measures and identified the sickest individuals among a cohort of children with chronic liver disease. This tool may have applicability to other children with chronic disease.",
keywords = "comprehensive clinical assessment, end-stage liver disease, frailty, pediatric liver transplantation",
author = "Eberhard Lurz and Claudia Quammie and Michael Englesbe and Alonso, {Estella M.} and Henry Lin and Hsu, {Evelyn K.} and Furuya, {Katryn N.} and Gupta, {Nitika A.} and Venkat, {Veena L.} and Daniel, {James F.} and Leonis, {Mike A.} and Tamir Miloh and Telega, {Grzegorz W.} and Jason Yap and Jerome Menendez and Book, {Linda S.} and Himes, {Ryan W.} and Sundaram, {Shikha S.} and Rulan Parekh and Chris Sonnenday and John Bucuvalas and Ng, {Vicky L.} and Kamath, {Binita M.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.jpeds.2017.10.066",
language = "English (US)",
volume = "194",
pages = "109--115.e4",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Frailty in Children with Liver Disease

T2 - A Prospective Multicenter Study

AU - Lurz, Eberhard

AU - Quammie, Claudia

AU - Englesbe, Michael

AU - Alonso, Estella M.

AU - Lin, Henry

AU - Hsu, Evelyn K.

AU - Furuya, Katryn N.

AU - Gupta, Nitika A.

AU - Venkat, Veena L.

AU - Daniel, James F.

AU - Leonis, Mike A.

AU - Miloh, Tamir

AU - Telega, Grzegorz W.

AU - Yap, Jason

AU - Menendez, Jerome

AU - Book, Linda S.

AU - Himes, Ryan W.

AU - Sundaram, Shikha S.

AU - Parekh, Rulan

AU - Sonnenday, Chris

AU - Bucuvalas, John

AU - Ng, Vicky L.

AU - Kamath, Binita M.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Objective: To assess frailty, a measure of physiologic declines in multiple organ systems, in children with chronic liver disease using a novel pediatric frailty tool. Study design: We performed a prospective cross-sectional multicenter study at 17 liver transplantation (LT) centers. 71 children (5–17 years of age), 36 with compensated chronic liver disease (CCLD) and 35 with end-stage liver disease (ESLD) and listed for LT, were assessed for frailty using validated pediatric tools to assess the 5 classic Fried Frailty Criteria—slowness, weakness, exhaustion, diminished physical activity, and shrinkage. Test scores were translated to age- and sex-dependent z scores, generating a maximum frailty score of 10. Results: The median frailty score of the cohort was 4 (IQR 3, 5). Subjects with ESLD had significantly higher frailty scores (median 5; IQR 4, 7) than subjects with CCLD (median 3; IQR 2, 4); (P <.0001). Area under the curve receiver operating characteristic for frailty scores to discriminate between ESLD and CCLD was 0.83 (95% CI 0.73, 0.93). Forty-six percent of children with ESLD were frail and there was no correlation between pediatric frailty scores and physician's global assessments (r = -0.24, 95% CI -0.53, 0.10). Conclusions: A novel frailty tool assessed additional dimensions of health, not captured by standard laboratory measures and identified the sickest individuals among a cohort of children with chronic liver disease. This tool may have applicability to other children with chronic disease.

AB - Objective: To assess frailty, a measure of physiologic declines in multiple organ systems, in children with chronic liver disease using a novel pediatric frailty tool. Study design: We performed a prospective cross-sectional multicenter study at 17 liver transplantation (LT) centers. 71 children (5–17 years of age), 36 with compensated chronic liver disease (CCLD) and 35 with end-stage liver disease (ESLD) and listed for LT, were assessed for frailty using validated pediatric tools to assess the 5 classic Fried Frailty Criteria—slowness, weakness, exhaustion, diminished physical activity, and shrinkage. Test scores were translated to age- and sex-dependent z scores, generating a maximum frailty score of 10. Results: The median frailty score of the cohort was 4 (IQR 3, 5). Subjects with ESLD had significantly higher frailty scores (median 5; IQR 4, 7) than subjects with CCLD (median 3; IQR 2, 4); (P <.0001). Area under the curve receiver operating characteristic for frailty scores to discriminate between ESLD and CCLD was 0.83 (95% CI 0.73, 0.93). Forty-six percent of children with ESLD were frail and there was no correlation between pediatric frailty scores and physician's global assessments (r = -0.24, 95% CI -0.53, 0.10). Conclusions: A novel frailty tool assessed additional dimensions of health, not captured by standard laboratory measures and identified the sickest individuals among a cohort of children with chronic liver disease. This tool may have applicability to other children with chronic disease.

KW - comprehensive clinical assessment

KW - end-stage liver disease

KW - frailty

KW - pediatric liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=85044465650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044465650&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2017.10.066

DO - 10.1016/j.jpeds.2017.10.066

M3 - Article

C2 - 29478492

AN - SCOPUS:85044465650

VL - 194

SP - 109-115.e4

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

ER -